# FDA Recalls 12 Million Over-the-Counter Eye Drops
The FDA has issued a nationwide recall affecting 12 million units of over-the-counter eye drops sold under multiple brand names. The agency warns consumers to stop using the affected products immediately and check their medicine cabinets.
The recall stems from contamination and sterility concerns that pose infection risks to users. Over-the-counter eye drops sit directly on the eye's surface, making them particularly vulnerable to bacterial and fungal contamination. Using compromised products can lead to serious ocular infections, ranging from mild conjunctivitis to vision-threatening keratitis.
This recall joins a pattern of eye drop safety issues that have troubled regulators. In 2023, the FDA investigated infections linked to artificial tear products, and independent testing revealed bacterial contamination in several popular brands. The eye care market contains thousands of products with minimal oversight compared to prescription medications.
Consumers should identify affected products by checking the FDA's official recall list, which includes specific brand names and lot numbers. The agency recommends disposing of suspect bottles in household trash and replacing them only with products from unaffected batches.
Anyone experiencing eye redness, pain, discharge, or vision changes after using the recalled drops needs immediate evaluation from an eye care professional. Ocular infections progress quickly and can cause permanent damage if left untreated.
The FDA advises consumers to purchase eye drops from reputable retailers and verify product authenticity. Checking expiration dates and storing drops properly, away from heat and direct light, reduces contamination risk. For chronic dry eye, speaking with an optometrist or ophthalmologist about prescription alternatives or safer over-the-counter options provides personalized guidance.